Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 29:10:659.
doi: 10.3389/fimmu.2019.00659. eCollection 2019.

Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum

Affiliations
Review

Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum

Sinuhe Hahn et al. Front Immunol. .

Abstract

Feto-maternal microchimerism (FMM) involves bidirectional cross-placental trafficking during pregnancy, leading to a micro-chimeric state that can persist for decades. In this manner a pregnant woman will harbor cells from her mother, as well as, cells from her child. Historically, eclampsia, a severe disorder of pregnancy provided the basis for FMM following the detection of trophoblast cells in the lungs of deceased women. Bi-directional cell trafficking between mother and fetus is also altered in pre-eclampsia and has been suggested to contribute to the underlying etiology. FMM has been implicated in tolerance promotion, remission of auto-inflammatory disorders during pregnancy, or the development of autoimmune conditions post-partum. The underlying mechanism whereby the host immune system is modulated is unclear but appears to involve HLA class II molecules, in that incompatibility between mother and fetus promotes remission of rheumatoid arthritis, whereas feto-maternal HLA compatibility may assist in the post-partum initiation of scleroderma. Couples having a high degree of HLA class II compatibility have an increased risk for pre-eclampsia, while the occurrence of scleroderma and rheumatoid arthritis is greater in pre-eclamptic cases than in women with normal pregnancies, suggesting a long term autoimmune predisposition. Since pregnant women with pre-eclampsia exhibit significantly lower levels of maternally-derived micro-chimerism, the question arises whether pre-eclampsia and post-partum development of autoimmune conditions occur due to the failure of the grandmothers cells to adequately regulate an inappropriate micro-chimeric constellation.

Keywords: autoimmunity; cell-free DNA; feto-maternal microchimerism; non-inherited-maternal-antigens; pre-eclampsia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Microchimerism throughout generations and risk of pre-eclampsia, RA and SSc development. Compatible or disparate expression of HLA of non-inherited antigen present in subsequent generation seam to promote or ameliorate autoimmunity or favor pre-eclampsia.

References

    1. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol. (2011) 204:193–201. 10.1016/j.ajog.2010.08.009 - DOI - PMC - PubMed
    1. Hahn S, Holzgreve W. Fetal cells and cell-free fetal DNA in maternal blood: new insights into pre-eclampsia. Hum Reprod Update. (2002) 8:501–8. 10.1093/humupd/8.6.501 - DOI - PubMed
    1. Hahn S, Huppertz B, Holzgreve W. Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation? Placenta. (2005) 26:515–26. 10.1016/j.placenta.2004.10.017 - DOI - PubMed
    1. Lapaire O, Holzgreve W, Oosterwijk JC, Brinkhaus R, Bianchi DW. Georg Schmorl on trophoblasts in the maternal circulation. Placenta. (2007) 28:1–5. 10.1016/j.placenta.2006.02.004 - DOI - PubMed
    1. Attwood HD, Park WW. Embolism to the lungs by trophoblast. J Obstet Gynaecol Br Commonw. (1961) 68:611–7. 10.1111/j.1471-0528.1961.tb02778.x - DOI - PubMed

Publication types